Since its inception, in 2000, Gavi, the Vaccine Alliance, which works with local governments to bring vaccines to low-income ...

The FDA has given the green light to expand the use of Moderna's vaccine for the treatment of RSV, the virus that causes ...

Gilead has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two mid-stage trials of ...

The Vaccines market is estimated to continue rising at a CAGR of 5.9%, reaching about USD 4,024.8 million by 2035 from USD 2,268.8 million in 2025. The vaccines market is a rapidly growing segment ...

A revamped U.S. vaccine advisory panel, appointed by Health Secretary Robert F. Kennedy Jr., voted 5-1 on Thursday to ...

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

The Advisory Committee on Immunization Practices (ACIP), made up of members recently hand-selected by Health and Human ...

The leader of the Kennedy-appointed vaccine panel said it will reconsider the government’s recommendations for childhood ...

The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...